ABIVAX
€83.50Change from previous close: −0.77%Absolute change: −€0.65
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 584 | 205 | 327 | 75.5 | — |
| Current assets | 551 | 171 | 286 | 36.2 | — |
| Cash and equivalents | 517 | 144 | 252 | 27.0 | — |
| Short-term investments | 13.7 | 0.0 | 9.1 | 0.0 | — |
| Receivables | 10.5 | 15.7 | 19.1 | 8.3 | — |
| Inventory | — | — | — | — | 4.0 |
| Net property, plant and equipment | 2.1 | 2.7 | 0.9 | 1.6 | — |
| Goodwill | 18.4 | 18.4 | 18.4 | 18.4 | — |
| Other intangible assets | 6.6 | 6.6 | 6.6 | 6.6 | — |
| Long-term investments | 0.0 | 0.1 | 0.1 | 0.0 | — |
| Current liabilities | 63.0 | 92.8 | 88.1 | 51.5 | — |
| Accounts payable | 37.6 | 43.8 | 47.2 | 15.5 | — |
| Long-term debt | — | 52.2 | 26.6 | 8.3 | 34.6 |
| Total debt | 1.9 | 97.4 | 58.0 | 39.2 | — |
| Total liabilities | 129 | 165 | 131 | 68.4 | — |
| Total equity (incl. minority) | 455 | 40.6 | 196 | 7.2 | — |
| Retained earnings | -738 | -439 | -283 | -144 | — |